83_FR_64373 83 FR 64134 - National Cancer Institute; Notice of Closed Meetings

83 FR 64134 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 239 (December 13, 2018)

Page Range64134-64135
FR Document2018-26960

Federal Register, Volume 83 Issue 239 (Thursday, December 13, 2018) 
[Federal Register Volume 83, Number 239 (Thursday, December 13, 2018)]
[Notices]
[Pages 64134-64135]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-26960]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with grant and/or 
contract proposals applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI UG1 and U24 Chemoprevention Clinical Trials Network.
    Date: January 15, 2019.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W102, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W102, Bethesda, MD 20892-9750, 240-276-6349, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-2: SBIR Contract Review.
    Date: February 6, 2019.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W102, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W102, Bethesda, MD 20892-9750, 240-276-6349, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-5: SBIR Contract Review.
    Date: February 21, 2019.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 6E034, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W260, Bethesda, MD 20892-9750, 240-276-5856, 
[email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group; Subcommittee I--Transition to Independence.
    Date: February 21-22, 2019.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Delia Tang, M.D., Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W602, Bethesda, MD 20892-9750, 240-276-6456, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; R25 Review.
    Date: March 6, 2019.
    Time: 1:00 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W110, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W110, Bethesda, MD 20892-9750, 240-276-6344, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; UH2/UH3 Review.
    Date: March 7, 2019.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W110, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W110, Bethesda, MD 20892-9750, 240-276-6344, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-8: NCI Clinical and Translational R21 and Omnibus R03.
    Date: March 7-8, 2019.
    Time: 6:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Reed Graves, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W106, Bethesda, MD 20892-9750, 240-276-6384, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Informatics Tools for Cancer Research and Surveillance.
    Date: March 21-22, 2019.
    Time: 5:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National

[[Page 64135]]

Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W260, 
Bethesda, MD 20892-9750, 240-276-5856, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-6: SBIR Contract Review.
    Date: April 18, 2019.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W106, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Reed Graves, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W106, 
Bethesda, MD 20892-9750, 240-276-6384, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: December 7, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-26960 Filed 12-12-18; 8:45 am]
 BILLING CODE 4140-01-P

64134 Federal Register / Vol. 83, No. 239 / Thursday, December 13, 2018 / Notices DEPARTMENT OF HEALTH AND and/or contract proposals and the Contact Person: Delia Tang, M.D., HUMAN SERVICES discussions could disclose confidential Scientific Review Officer, Research Programs trade secrets or commercial property Review Branch, Division of Extramural National Institutes of Health Activities, National Cancer Institute, NIH, such as patentable material, and 9609 Medical Center Drive, Room 7W602, personal information concerning Bethesda, MD 20892–9750, 240–276–6456, National Institute of Biomedical individuals associated with grant and/or tangd@mail.nih.gov. Imaging and Bioengineering; Notice of contract proposals applications, the Closed Meeting Name of Committee: National Cancer disclosure of which would constitute a Institute Special Emphasis Panel; R25 Pursuant to section 10(d) of the clearly unwarranted invasion of Review. Federal Advisory Committee Act, as personal privacy. Date: March 6, 2019. amended, notice is hereby given of a Name of Committee: National Cancer Time: 1:00 p.m. to 4:30 p.m. Agenda: To review and evaluate grant meeting of the National Institute of Institute Special Emphasis Panel; NCI UG1 and U24 Chemoprevention Clinical Trials applications. Biomedical Imaging and Bioengineering Place: National Cancer Institute, Shady Special Emphasis Panel. Network. Date: January 15, 2019. Grove, 9609 Medical Center Drive, Room The meetings will be closed to the 7W110, Rockville, MD 20850, (Telephone Time: 10:00 a.m. to 6:00 p.m. public in accordance with the Agenda: To review and evaluate grant Conference Call). provisions set forth in sections applications. Contact Person: Robert E. Bird, Ph.D., 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Place: National Cancer Institute, Shady Scientific Review Officer, Research Program as amended. The grant applications and Grove, 9609 Medical Center Drive, Room Review Branch, Division of Extramural the discussions could disclose 7W102, Rockville, MD 20850, (Telephone Activities, National Cancer Institute, NIH, confidential trade secrets or commercial Conference Call). 9609 Medical Center Drive, Room 7W110, Contact Person: Shakeel Ahmad, Ph.D., Bethesda, MD 20892–9750, 240–276–6344, property such as patentable material, Scientific Review Officer, Research birdr@mail.nih.gov. and personal information concerning Technology and Contract Review Branch, Name of Committee: National Cancer individuals associated with the grant Division of Extramural Activities, National Institute Special Emphasis Panel; UH2/UH3 applications, the disclosure of which Cancer Institute, NIH, 9609 Medical Center Review. would constitute a clearly unwarranted Drive, Room 7W102, Bethesda, MD 20892– Date: March 7, 2019. invasion of personal privacy. 9750, 240–276–6349, ahmads@mail.nih.gov. Time: 1:00 p.m. to 3:00 p.m. Name of Committee: National Institute of Name of Committee: National Cancer Agenda: To review and evaluate grant Biomedical Imaging and Bioengineering; Institute Special Emphasis Panel; TEP–2: applications. Special Emphasis Panel BRAIN Initiative: SBIR Contract Review. Place: National Cancer Institute, Shady Theories, Models and Methods for Analysis Date: February 6, 2019. Grove, 9609 Medical Center Drive, Room of Complex Data from the Brain (2019/5). Time: 10:00 a.m. to 6:00 p.m. 7W110, Rockville, MD 20850, (Telephone Date: January 16, 2019. Agenda: To review and evaluate grant Conference Call). Time: 8:00 a.m. to 7:00 p.m. applications. Contact Person: Robert E. Bird, Ph.D., Agenda: To review and evaluate grant Place: National Cancer Institute, Shady Scientific Review Officer, Research Program applications. Grove, 9609 Medical Center Drive, Room Review Branch, Division of Extramural 7W102, Rockville, MD 20850, (Telephone Activities, National Cancer Institute, NIH, Place: The Dupont Circle, 1500 New Conference Call). 9609 Medical Center Drive, Room 7W110, Hampshire Avenue NW, Washington, DC Contact Person: Shakeel Ahmad, Ph.D., Bethesda, MD 20892–9750, 240–276–6344, 20036. Scientific Review Officer, Research birdr@mail.nih.gov. Contact Person: Dennis Hlasta, Ph.D., Technology and Contract Review Branch, Scientific Review Officer, National Institute Name of Committee: National Cancer Division of Extramural Activities, National of Biomedical Imaging and Bioengineering, Institute Special Emphasis Panel; SEP–8: NCI Cancer Institute, NIH, 9609 Medical Center National Institutes of Health, 6707 Drive, Room 7W102, Bethesda, MD 20892– Clinical and Translational R21 and Omnibus Democracy Blvd., Bethesda, MD 20892, (301) 9750, 240–276–6349, ahmads@mail.nih.gov. R03. 496–4794, dennis.hlasta@mail@nih.gov. Date: March 7–8, 2019. Name of Committee: National Cancer Time: 6:00 p.m. to 4:00 p.m. Dated: December 7, 2018. Institute Special Emphasis Panel; TEP–5: Agenda: To review and evaluate grant Sylvia L. Neal, SBIR Contract Review. applications. Program Analyst, Office of Federal Advisory Date: February 21, 2019. Place: Bethesda North Marriott Hotel & Committee Policy. Time: 8:00 a.m. to 4:00 p.m. Conference Center, 5701 Marinelli Road, Agenda: To review and evaluate contract [FR Doc. 2018–26959 Filed 12–12–18; 8:45 am] North Bethesda, MD 20852. proposals. Contact Person: Reed Graves, Ph.D., BILLING CODE 4140–01–P Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room Scientific Review Officer, Research 6E034, Rockville, MD 20850, (Telephone Technology and Contract Review Branch, Conference Call). Division of Extramural Activities, National DEPARTMENT OF HEALTH AND Cancer Institute, NIH, 9609 Medical Center HUMAN SERVICES Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, Research Drive, Room 7W106, Bethesda, MD 20892– Technology and Contract Review Branch, 9750, 240–276–6384, gravesr@mail.nih.gov. National Institutes of Health Division of Extramural Activities, National Name of Committee: National Cancer National Cancer Institute; Notice of Cancer Institute, NIH, 9609 Medical Center Institute Special Emphasis Panel; Informatics Drive, Room 7W260, Bethesda, MD 20892– Tools for Cancer Research and Surveillance. Closed Meetings 9750, 240–276–5856, nadeem.khan@nih.gov. Date: March 21–22, 2019. Pursuant to section 10(d) of the Name of Committee: National Cancer Time: 5:00 p.m. to 4:00 p.m. Federal Advisory Committee Act, as Institute Initial Review Group; Subcommittee Agenda: To review and evaluate grant amozie on DSK3GDR082PROD with NOTICES1 amended, notice is hereby given of the I—Transition to Independence. applications. Date: February 21–22, 2019. Place: Bethesda North Marriott Hotel & following meetings. Conference Center, 5701 Marinelli Road, The meetings will be closed to the Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract North Bethesda, MD 20852. public in accordance with the proposals. Contact Person: Nadeem Khan, Ph.D., provisions set forth in sections Place: Bethesda North Marriott Hotel & Scientific Review Officer, Research 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Conference Center, 5701 Marinelli Road, Technology and Contract Review Branch, as amended. The grant applications Bethesda, MD 20852. Division of Extramural Activities, National VerDate Sep<11>2014 17:12 Dec 12, 2018 Jkt 247001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM 13DEN1

Federal Register / Vol. 83, No. 239 / Thursday, December 13, 2018 / Notices 64135 Cancer Institute, NIH, 9609 Medical Center personal information concerning DEPARTMENT OF HOMELAND Drive, Room 7W260, Bethesda, MD 20892– individuals associated with the grant SECURITY 9750, 240–276–5856, nadeem.khan@nih.gov. applications and/or contract proposals, Name of Committee: National Cancer the disclosure of which would Federal Emergency Management Institute Special Emphasis Panel; TEP–6: Agency SBIR Contract Review. constitute a clearly unwarranted Date: April 18, 2019. invasion of personal privacy. [Docket ID FEMA–2018–0002; Internal Time: 10:00 a.m. to 7:00 p.m. Name of Committee: National Deafness and Agency Docket No. FEMA–B–1871] Agenda: To review and evaluate contract Other Communication Disorders Advisory proposals. Changes in Flood Hazard Place: National Cancer Institute, Shady Council. Determinations Grove, 9609 Medical Center Drive, Room Date: January 25, 2019. 7W106, Rockville, MD 20850, (Telephone Closed: 8:30 a.m. to 9:40 a.m. AGENCY: Federal Emergency Conference Call). Agenda: To review and evaluate grant Management Agency, DHS. Contact Person: Reed Graves, Ph.D., applications. ACTION: Notice. Scientific Review Officer, Special Review Place: National Institutes of Health, Branch, Division of Extramural Activities, Neuroscience Center, Room C and D, 6001 SUMMARY: This notice lists communities National Cancer Institute, NIH, 9609 Medical Executive Boulevard, Rockville, MD 20852. where the addition or modification of Center Drive, Room 7W106, Bethesda, MD 20892–9750, 240–276–6384, gravesr@ Open: 9:40 a.m. to 1:50 p.m. Base Flood Elevations (BFEs), base flood mail.nih.gov. Agenda: Staff reports on divisional, depths, Special Flood Hazard Area (Catalogue of Federal Domestic Assistance programmatical, and special activities. (SFHA) boundaries or zone Program Nos. 93.392, Cancer Construction; Place: National Institutes of Health, designations, or the regulatory floodway 93.393, Cancer Cause and Prevention Neuroscience Center, Room C and D, 6001 (hereinafter referred to as flood hazard Research; 93.394, Cancer Detection and Executive Boulevard, Rockville, MD 20852. determinations), as shown on the Flood Diagnosis Research; 93.395, Cancer Contact Person: Craig A. Jordan, Ph.D., Insurance Rate Maps (FIRMs), and Treatment Research; 93.396, Cancer Biology Director, Division of Extramural Activities, where applicable, in the supporting Research; 93.397, Cancer Centers Support; NIDCD, NIH, Room 8345, MSC 9670, 6001 Flood Insurance Study (FIS) reports, 93.398, Cancer Research Manpower; 93.399, Executive Blvd., Bethesda, MD 20892–9670, prepared by the Federal Emergency Cancer Control, National Institutes of Health, 301–496–8693, jordanc@nidcd.nih.gov. HHS) Management Agency (FEMA) for each Any interested person may file written community, is appropriate because of Dated: December 7, 2018. comments with the committee by forwarding new scientific or technical data. The Melanie J. Pantoja, the statement to the Contact Person listed on FIRM, and where applicable, portions of Program Analyst, Office of Federal Advisory this notice. The statement should include the the FIS report, have been revised to Committee Policy. name, address, telephone number and when reflect these flood hazard [FR Doc. 2018–26960 Filed 12–12–18; 8:45 am] applicable, the business or professional determinations through issuance of a BILLING CODE 4140–01–P affiliation of the interested person. Letter of Map Revision (LOMR), in In the interest of security, NIH has accordance with Federal Regulations. instituted stringent procedures for entrance The LOMR will be used by insurance DEPARTMENT OF HEALTH AND onto the NIH campus. All visitor vehicles, agents and others to calculate HUMAN SERVICES including taxicabs, hotel, and airport shuttles appropriate flood insurance premium will be inspected before being allowed on rates for new buildings and the contents National Institutes of Health campus. Visitors will be asked to show one of those buildings. For rating purposes, form of identification (for example, a the currently effective community National Institute on Deafness and government-issued photo ID, driver’s license, Other Communication Disorders; number is shown in the table below and or passport) and to state the purpose of their Notice of Meeting must be used for all new policies and visit. renewals. Pursuant to section 10(d) of the Information is also available on the Institute’s/Center’s home page: https:// DATES: These flood hazard Federal Advisory Committee Act, as www.nidcd.nih.gov/about/advisory-council, determinations will be finalized on the mentioned, notice is hereby given of a where an agenda and any additional dates listed in the table below and meeting of the National Deafness and information for the meeting will be posted revise the FIRM panels and FIS report Other Communication Disorders when available. in effect prior to this determination for Advisory Council. The meeting will be open to the (Catalogue of Federal Domestic Assistance the listed communities. Program Nos. 93.173, Biological Research From the date of the second public as indicated below, with Related to Deafness and Communicative publication of notification of these attendance limited to space available. Disorders, National Institutes of Health, HHS) changes in a newspaper of local Individuals who plan to attend and circulation, any person has 90 days in need special assistance, such as sign Dated: December 7, 2018. which to request through the language interpretation or other Sylvia L. Neal, community that the Deputy Associate reasonable accommodations, should Program Analyst, Office of Federal Advisory Administrator for Insurance and notify the Contact Person listed below Committee Policy. Mitigation reconsider the changes. The in advance of the meeting. The meeting will be closed to the [FR Doc. 2018–26958 Filed 12–12–18; 8:45 am] flood hazard determination information public in accordance with the BILLING CODE 4140–01–P may be changed during the 90-day amozie on DSK3GDR082PROD with NOTICES1 provisions set forth in sections period. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., ADDRESSES: The affected communities as amended. The grant applications are listed in the table below. Revised and/or contract proposals and the flood hazard information for each discussions could disclose confidential community is available for inspection at trade secrets or commercial property both the online location and the such as patentable material, and respective community map repository VerDate Sep<11>2014 17:12 Dec 12, 2018 Jkt 247001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM 13DEN1


Document Created: 2018-12-13 01:16:16
Document Modified: 2018-12-13 01:16:16
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJanuary 15, 2019.
FR Citation83 FR 64134 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR